Feasibility of subantimicrobial-dose doxycycline for elbow tendinopathy
Patients with elbow tendinopathy tolerated SD doxycycline well and the majority were compliant with a twice-daily regimen for 12 weeks. Our cohort demonstrated improvements in symptoms and grip strength. Further research is needed to determine if SD doxycycline contributes to this improvement.
Authors
- Jamie Egbert (ORCID: https://orcid.org/0000-0001-6288-8058)
- Harry G. Greditzer (ORCID: https://orcid.org/0000-0002-6161-5426)
- Andy O. Miller (ORCID: https://orcid.org/0000-0003-2762-0878)
- Miguel Otero (ORCID: https://orcid.org/0000-0002-4945-2994)
- Scott Alan Rodeo (ORCID: https://orcid.org/0000-0002-0745-9880)
- Brianna Quijano
- Brett G. Toresdahl (ORCID: https://orcid.org/0000-0003-3857-2779)
- Joshua S. Dines (ORCID: https://orcid.org/0000-0002-2135-9317)
Institutions
- Hospital for Special Surgery (US)
- Cornell University (US)
- University of Utah (US)
Publication Details
- Journal
- JSES International
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1016/j.jseint.2025.03.019
- Primary Topic
- Tendon Structure and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Hospital for Special Surgery